World's Best Scientists 2026 revealed!
Reginald M. Gorczynski

Reginald M. Gorczynski

D-Index & Metrics

Immunology

D-Index
67
Citations
13168
World Ranking
2701
National Ranking
60

Reginald M. Gorczynski publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Reginald M. Gorczynski sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 413 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Reginald M. Gorczynski D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Reginald M. Gorczynski sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Reginald M. Gorczynski is affiliated with the University of Toronto in Canada and has contributed to the field of medicine, with a focus on immunology, infectious diseases, oncology, molecular biology, and surgery. Their research spans several key areas involving immune responses, cancer biology, and respiratory diseases.

Their recent scholarly output includes notable papers such as "IL-17 Signaling in the Tumor Microenvironment" (2020, Advances in experimental medicine and biology), "Nature of Acquired Immune Responses, Epitope Specificity and Resultant Protection from SARS-CoV-2" (2021, Journal of Personalized Medicine), along with contributions to collaborative works including "High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment" (2024, Frontiers in Immunology).

Reginald M. Gorczynski's publication record spans various peer-reviewed journals, prominently featuring venues such as Advances in genetics, Frontiers in Endocrinology, Frontiers in Immunology, Advances in experimental medicine and biology, and the Journal of Personalized Medicine.

Themself has co-authored multiple papers with a network of frequent collaborators including Edward J. Steele, Robyn A. Lindley, Robert Temple, Gensuke Tokoro, and N. C. Wickramasinghe.

Research interests and topics covered include:

  • SARS-CoV-2 and COVID-19 Research
  • Galectins and Cancer Biology
  • Cancer Immunotherapy and Biomarkers
  • Asthma and respiratory diseases
  • Immune cells in cancer
  • Psoriasis: Treatment and Pathogenesis
  • Lymphatic System and Diseases

Subfields within medicine that have been a focus in their work consist of:

  • Immunology
  • Infectious Diseases
  • Oncology
  • Molecular Biology
  • Surgery

In addition to journal articles, Gorczynski has published books through World Scientific, including the 2022 title "Understanding the Origin and Global Spread of COVID-19."

The combination of their work reflects a multidisciplinary approach to the medical sciences with emphasis on immune system mechanisms, cancer biology, infectious disease processes, and implications for treatment strategies.

Best Publications

  • Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection

    Yen-Tung A. Teng;Hai Nguyen;Xuijuan Gao;Young-Yun Kong

  • Ribavirin Inhibits Viral-Induced Macrophage Production of TNF, IL-1, the Procoagulant fgl2 Prothrombinase and Preserves Th1 Cytokine Production But Inhibits Th2 Cytokine Response

    Qin Ning;D. Brown;J. Parodo;M. Cattral

  • Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival

    Wei-Ping Min;Reginald Gorczynski;Xu-Yan Huang;Michelle Kushida

  • The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

    Philip A. Marsden;Qin Ning;Laisum S. Fung;Xioping Luo

  • Conditioned immune response associated with allogeneic skin grafts in mice.

    R M Gorczynski;S Macrae;M Kennedy

  • Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice

    Nadine De Albuquerque;Ehtesham Baig;Xuezhong Ma;Jianhua Zhang

  • An Immunoadhesin Incorporating the Molecule OX-2 Is a Potent Immunosuppressant That Prolongs Allo- and Xenograft Survival

    Reginald M. Gorczynski;Mark S. Cattral;Zhigi Chen;Jiang Hu

  • Soluble Fibrinogen-Like Protein 2/Fibroleukin Exhibits Immunosuppressive Properties: Suppressing T Cell Proliferation and Inhibiting Maturation of Bone Marrow-Derived Dendritic Cells

    Camie W. Y. Chan;Lyndsey S. Kay;Rachel G. Khadaroo;Matthew W. C. Chan

  • Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.

    Reginald M. Gorczynski

  • CD200 Is a Ligand for All Members of the CD200R Family of Immunoregulatory Molecules

    Reginald Gorczynski;Zhiqi Chen;Yu Kai;Lydia Lee

  • Augmented Induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R.

    Reginald M Gorczynski;Lydia Lee;Ivo Boudakov

  • CD200 Immunoadhesin Suppresses Collagen-Induced Arthritis in Mice

    Reginald M. Gorczynski;Zhiqi Chen;Kai Yu;Jiang Hu

  • CD200 and its receptors as targets for immunoregulation.

    Reginald M Gorczynski

  • Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2

    David A. Clark;Jin-Wen Ding;Gary Yu;Gary A. Levy

  • The same immunoregulatory molecules contribute to successful pregnancy and transplantation.

    Reginald M. Gorczynski;Sima Hadidi;Gary Yu;David A. Clark

  • The FGL2-FcγRIIB pathway: A novel mechanism leading to immunosuppression

    Hao Liu;Itay Shalev;Justin Manuel;Wei He

  • Increased expression of the novel molecule OX-2 is involved in prolongation of murine renal allograft survival.

    Reginald M. Gorczynski;Zhiqi Chen;Xin-Ming Fu;Hua Zeng

  • Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage.

    Reginald M. Gorczynski;Z. Chan;S. Chung;Z. Cohen

  • Evidence That an OX-2-Positive Cell Can Inhibit the Stimulation of Type 1 Cytokine Production by Bone Marrow-Derived B7-1 (and B7-2)-Positive Dendritic Cells

    Laura Gorczynski;Z. Chen;J. Hu;Y. Kai

  • Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo.

    Reginald M. Gorczynski;Kai Yu;David Clark;David Clark

Frequent Co-Authors

David A. Clark
David A. Clark McMaster University
Gary A. Levy
Gary A. Levy University of Toronto
Jean-Pierre Mach
Jean-Pierre Mach University of Lausanne
Otto Westphal
Otto Westphal Max Planck Society
Philip A. Marsden
Philip A. Marsden University of Toronto
Artur J. Ulmer
Artur J. Ulmer University of Freiburg
Klaus Brandenburg
Klaus Brandenburg Leibniz Institute for Neurobiology
Ulrich Zähringer
Ulrich Zähringer Research Center Borstel - Leibniz-Center for Medicine and Biosciences
Ernst Th. Rietschel
Ernst Th. Rietschel Institute for Advanced Sustainability Studies
Jean Gariépy
Jean Gariépy University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various allied health professions, many of which offer flexible online education options. For those interested in nursing pathways, programs like the easiest accelerated nursing programs provide a fast-tracked route to becoming a registered nurse, blending foundational science knowledge with clinical skills.

Additionally, entry-level options such as the best easiest lpn programs to get into allow students to quickly gain licensure and hands-on experience in patient care, often serving as stepping stones toward advanced immunology-related roles in healthcare settings.

For those aiming for leadership roles in clinical care, exploring easy nurse practitioner programs to get into can be highly beneficial. These programs prepare graduates for autonomous practice and specialized healthcare delivery, often integrating immunological principles.

Moreover, mental health is tightly connected to immune function, making the availability of online pmhnp programs with clinical placement an attractive option for those seeking to merge psychiatric nursing with immunology expertise. Clinical placements provide essential hands-on experience, crucial for bridging theory and practice.

Choosing the right online program aligned with your career goals can enhance your understanding of Immunology and expand your professional opportunities in healthcare.

Best Scientists Citing Reginald M. Gorczynski

Trending Scientists

Recently Published Articles